Status:
ACTIVE_NOT_RECRUITING
Anti-osteoporosis Medication Monitoring and Management Service
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Osteoporosis
Fracture
Eligibility:
All Genders
50+ years
Brief Summary
BACKGROUND: One-year adherence to oral anti-osteoporosis medication (AOMs) was only about 30%. In recent years, efforts have been made to change the delivery of these medications from oral form to in...
Eligibility Criteria
Inclusion
- Age \>=50 and one of the below
- Newly prescribed with AOMs
- Recent change of AOMs
- Poor adherence to AOMs
- Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements.
Exclusion
- Life expectancy less than 2 years or can't be assessed for communication problems
- patient in our fracture liaison service or other medication clinical trials
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02194647
Start Date
July 1 2014
End Date
July 1 2026
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100